Sorry if this has been posted already. News is a few days old, but it is a positive for DVAX pipeline value.
mild liver toxicity. This is ridiculous.
They had a brief call, I signed on for a few minutes, over now. From what I heard. The Mayo trial is not on hold but think for now, it is likely to be delayed (poor patients getting screwed by the JAK mafia if that happens ~my editorial not Chip's). Dosage is about the same for Imetelstat PV/EV as MF but is tapered faster with MF patients. Key is the Liver Function low-grade reversed after treatment stops. They don't have this data as the patients are not followed after dosage ends, but they will attempt to get it, not easy though.
Cover for insider selling for bad news yet to be made public. This is typical SEC rule skipping by Wall Street. This qtr report will likely be hugely disappointing.
What if the future price of FB is $55, per UBS Meltdown comment today? In that case, she'd have her bags packed already.
Keeping details private, but things going well.
Just a guess